Use Options For a Chance To Buy HZNP at a 47% Discount

Looking back to 2 days ago, Horizon Pharma plc (HZNP) priced a 15,350,000 share secondary stock offering at $28.25 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time and based on early trading on Friday, the stock is now 8.1% above the offering price..